OxThera stock price, funding rounds, valuation and financials

OxThera has raised $53.30 m in total funding. OxThera annual revenue was kr11.01 m in FY 2015

KR11 M

OxThera Revenue FY, 2015

OxThera Revenue growth (FY, 2014 - FY, 2015), %25%

OxThera Net income (FY, 2015)-37.8 M

OxThera EBITDA (FY, 2015)-34.7 M

OxThera EBIT (FY, 2015)-34.8 M

OxThera Cash, 31-Dec-20158.9 M

OxThera total Funding	$53.3 m
OxThera investors	Sunstone Capital, Idinvest Partners, Industrifonden, SLS Venture, HealthCap, Q-Med

SEK	FY, 2013	FY, 2014	FY, 2015
Revenue	3.8m	8.8m	11.0m
Revenue growth, %		131%	25%
Sales and marketing expense		64.2m	37.8m
General and administrative expense	4.8m	7.7m	7.8m
Operating expense total	4.8m	72.1m	45.7m
Depreciation and amortization		134.2k	100.3k
EBITDA	(33.6m)	(63.3m)	(34.7m)
EBITDA margin, %	(880%)	(720%)	(315%)
EBIT	(3.4m)	(63.5m)	(34.8m)
EBIT margin, %	(88%)	(721%)	(316%)
Net Income	(33.5m)	(69.3m)	(37.8m)